laura johanna van veer born dutch molecular biologist clinical molecular geneticist group leader molecular pathology department pathology division experimental therapy netherlands cancer attended university amsterdam received bsc biology msc molecular oncology continued studies university leiden would earn phd focusing study oncogene activation tumorigenesis van veer cofounded agendia bv serving chief operating officer agendia bv june continues work company today chief research featured cover story issue cancer colleagues field awarded number patents related cancer member science policy government affairs committee american association cancer research since member education training peer reviewed publications